Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance

Overview

In the highly regulated pharmaceutical landscape, ensuring the quality, safety, and efficacy of drug products hinges on meticulous analysis, robust quality systems, and strict adherence to regulatory guidelines. Among the multifaceted challenges faced by pharmaceutical scientists, the control and characterization of impurities, the mitigation of nitrosamine risks, the assessment of extractables, leachables, and the establishment of product stability are paramount.

This critical domain requires a deep understanding of advanced analytical techniques, evolving regulatory expectations, and proactive risk management strategies. The identification, quantification, and qualification of various types of impurities – be they organic, inorganic, residual solvents, or elemental – demand sophisticated methodologies and a thorough grasp of ICH guidelines (Q3A, Q3B, Q3C, Q3D). Furthermore, the recent emergence of nitrosamines as a significant safety concern necessitates a comprehensive understanding of their formation pathways, effective risk assessment protocols, and sensitive analytical detection methods (ICH M7).

Successfully navigating these complexities demands a holistic approach, integrating cutting-edge analytical tools, a strong quality mindset, and a thorough understanding of global regulatory expectations. Pharmaceutical professionals must continuously update their knowledge and skills to effectively address these critical aspects and ensure the delivery of safe and effective medicines to patients.

Who Should Attend This Masterclass?

This intensive masterclass, "Navigating Complexities in Pharmaceutical Analysis, Quality & Regulatory Compliance: Impurities, Nitrosamines, Extractables, and Stability," is specifically designed for professionals working within the pharmaceutical industry who are involved in the critical aspects of drug development, manufacturing, and quality assurance. The target audience includes, but is not limited to:

Analytical Scientists: Those involved in method development, validation, routine testing, and impurity profiling of drug substances and drug products.

Quality Control (QC) Analysts and Managers: Professionals responsible for ensuring the quality of raw materials, intermediates, and finished products through analytical testing and compliance with specifications.

Quality Assurance (QA) Specialists and Managers: Individuals focused on establishing and maintaining quality systems, overseeing GMP compliance, managing deviations, and ensuring adherence to regulatory requirements.

Regulatory Affairs Professionals: Those responsible for preparing and submitting regulatory dossiers, interacting with health authorities, and ensuring compliance with global regulations related to impurities, stability, and overall product quality.

Formulation Scientists: Individuals involved in the development of drug products who need to understand the impact of impurities and packaging on product stability and quality.

Stability Scientists: Professionals dedicated to designing, executing, and interpreting stability studies to determine product shelf life and storage conditions.

Team Leaders and Directors: Those looking to enhance their team's understanding of critical quality and regulatory aspects related to impurities, nitrosamines, extractables, and stability.

Individuals seeking to deepen their knowledge of the latest ICH guidelines, analytical techniques, and best practices in pharmaceutical quality and regulatory compliance.

Specifically, this masterclass will be highly beneficial for scientists looking to expand their expertise and take on more complex responsibilities, professionals seeking a comprehensive update on current regulatory expectations and emerging challenges like nitrosamine contamination, individuals aiming to improve their understanding of risk assessment and mitigation strategies for impurities and related quality attributes and those involved in handling OOS/OOT investigations and interacting with regulatory agencies.

By attending this masterclass, participants will gain practical knowledge and insights that can be directly applied to their daily work, contributing to improved product quality, enhanced regulatory compliance, and ultimately, patient safety.

Organizing Secretaries

Ms Swati Kanwar; E: s.kanwar@glostem.com; M: 8289015050

Ms Farheen Zainab; f.zainab@glostem.com; M: 7696225050

WhatsApp: 9041725050 for more information.